PERSPECTIVE THERAPEUTICS, INC. Current Assets
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Current Assets of $241.52 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-10
- 2026-06-30: Assets, Current $241.52M.
- 2026-03-31: Assets, Current $275.35M.
- 2025-12-31: Assets, Current $148.39M.
- 2025-09-30: Assets, Current $178.50M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $241.52M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $275.35M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $148.39M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $178.50M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $195.96M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $215.74M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $231.16M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $270.17M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $294.24M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $188.20M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $16.84M 10-K/A · filed 2025-03-28 | |
| 2023-09-30 | $21.69M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $31.95M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $40.27M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $53.22M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $57.54M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $59.33M 10-KT · filed 2023-05-01 | |
| 2022-03-31 | $62.76M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $63.60M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $64.96M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $67.30M 10-KT · filed 2023-05-01 | |
| 2021-03-31 | $68.07M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $12.29M 10-Q · filed 2021-02-09 | |
| 2020-09-30 | $4.75M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $5.51M 10-K · filed 2021-09-27 | |
| 2020-03-31 | $5.72M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $5.63M 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $6.81M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $7.32M 10-K · filed 2020-09-25 | |
| 2019-03-31 | $8.43M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $9.82M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $11.27M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.45M 10-K · filed 2019-09-27 | |
| 2018-03-31 | $6.33M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $7.42M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $8.87M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.29M 10-K · filed 2018-09-26 | |
| 2017-03-31 | $11.92M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $13.18M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $14.93M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.63M 10-K · filed 2017-09-28 | $13.63M 10-K · filed 2016-09-09 |
| 2016-03-31 | $13.24M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $14.28M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $15.34M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $16.33M 10-K · filed 2016-09-09 | |
| 2015-03-31 | $11.89M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $12.83M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $13.73M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $19.21M 10-K · filed 2015-09-14 | |
| 2014-03-31 | $25.11M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $5.92M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $6.90M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $4.44M 10-K · filed 2014-09-29 | |
| 2013-03-31 | $5.09M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $5.74M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $6.50M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.14M 10-K · filed 2013-09-30 | |
| 2012-03-31 | $4.01M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $5.16M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $3.56M 10-Q/A · filed 2011-12-13 | |
| 2011-06-30 | $4.22M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |